2023
Impact of the COVID-19 pandemic on treatment approaches of multiple myeloma
Theprungsirikul P, Neparidze N. Impact of the COVID-19 pandemic on treatment approaches of multiple myeloma. Medical Research Archives 2023, 11 DOI: 10.18103/mra.v11i6.3912.Peer-Reviewed Original ResearchMultiple myelomaCOVID-19 infectionHematologic malignanciesTreatment approachesCOVID-19 pandemicAutologous stem cell transplantCoronavirus disease-19 (COVID-19) patientsImmune therapy approachesCellular immune dysfunctionRefractory multiple myelomaManagement of patientsStem cell transplantClinical practice guidelinesCommon hematologic malignancySevere clinical outcomesEarly pandemic periodCOVID-19Stable diseaseMajor comorbiditiesSteroid regimensCytotoxic chemotherapySupportive careImmune dysfunctionPrompt diagnosisTreatment initiation
2016
Evolving Immunotherapy Approaches for Renal Cell Carcinoma
Curtis SA, Cohen JV, Kluger HM. Evolving Immunotherapy Approaches for Renal Cell Carcinoma. Current Oncology Reports 2016, 18: 57. PMID: 27475806, DOI: 10.1007/s11912-016-0542-9.Peer-Reviewed Original ResearchConceptsRenal cell carcinomaMetastatic renal cell carcinomaCell carcinomaImmune therapy approachesCheckpoint inhibitorsCytokine therapyCytotoxic chemotherapyOverall survivalImmunotherapy approachesVaccine therapyImmune therapyImmune systemTherapyCell therapyCarcinomaTherapy approachesHigh rateSurvivalMorbidityChemotherapyMortality
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply